19/09/2022: Theradiag announces its results for the first half of 2022: breaking-even and confirming its ability to be structurally profitable from early 2023 Post author:Ingrid Chemin Post published:19 September 2022 Post category:Press Releases Continue Reading19/09/2022: Theradiag announces its results for the first half of 2022: breaking-even and confirming its ability to be structurally profitable from early 2023
18/07/2022: Theradiag reports revenue of €6.3 million for the first half of 2022, up 14.3% Post author:Ingrid Chemin Post published:18 July 2022 Post category:Press Releases Continue Reading18/07/2022: Theradiag reports revenue of €6.3 million for the first half of 2022, up 14.3%
08/06/2022: Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics Post author:Ingrid Chemin Post published:8 June 2022 Post category:Press Releases Continue Reading08/06/2022: Quotient Limited and Theradiag Announce Partnership to Advance Autoimmune Disease Diagnostics
